This inventor holds 1 USPTO granted patent. Top assignees: Xiamen Kingdomway Biotech. Co., Ltd., Xiamen Kingdomway Group Company. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Suxia Xu: Innovator in Cardiovascular Health
Introduction
Suxia Xu is a notable inventor based in Fujian, China. He has made significant contributions to the field of health and nutrition, particularly in the prevention and treatment of cardiovascular and cerebrovascular diseases. His innovative work has led to the development of a unique composition aimed at improving health outcomes.
Latest Patents
Suxia Xu holds a patent for a composition designed for preventing and/or treating cardiovascular and cerebrovascular diseases. This invention includes a method for preparing the composition, which comprises at least two of the following components: docosahexaenoic acid or an ester thereof, coenzyme Q10, lipoic acid, and phospholipid. The composition is intended for use in dietary supplements or health foods, specifically targeting dyslipidemia and related cardiovascular conditions.
Career Highlights
Throughout his career, Suxia Xu has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Xiamen Kingdomway Group Company and Xiamen Kingdomway Biotech Co., Ltd. His work in these organizations has allowed him to further his research and development efforts in health-related innovations.
Collaborations
Suxia Xu has collaborated with several professionals in his field, including Fangfang Chen and Weicheng Liao. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.
Conclusion
Suxia Xu is a distinguished inventor whose work in cardiovascular health has the potential to make a significant impact on public health. His innovative compositions and dedication to research exemplify the importance of advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile